Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Noto

Showing results (91-100 of 93) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 93 results.
Liver International : Official Journal of the International Association for the Study of the Liver|February 20, 2024
Mitochondrial amidoxime-reducing component 1 p.Ala165Thr increases protein degradation mediated by the proteasomeTanmoy Dutta, Kavitha Sasidharan, Ester Ciociola, et al.
Psychopharmacology|April 5, 2005
Randomized clinical trial to compare the effects of methadone and buprenorphine on the immune system in drug abusersS Neri, C M Bruno, D Pulvirenti, et al.
Clinical and Molecular Hepatology|December 24, 2024
Downregulation of the MARC1 p.A165 risk allele reduces hepatocyte lipid content by increasing beta-oxidationEster Ciociola, Tanmoy Dutta, Kavitha Sasidharan, et al.
Pageof 10

Showing results (91-100 of 93) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 93 results.
Liver International : Official Journal of the International Association for the Study of the Liver|February 20, 2024
Mitochondrial amidoxime-reducing component 1 p.Ala165Thr increases protein degradation mediated by the proteasomeTanmoy Dutta, Kavitha Sasidharan, Ester Ciociola, et al.
Psychopharmacology|April 5, 2005
Randomized clinical trial to compare the effects of methadone and buprenorphine on the immune system in drug abusersS Neri, C M Bruno, D Pulvirenti, et al.
Clinical and Molecular Hepatology|December 24, 2024
Downregulation of the MARC1 p.A165 risk allele reduces hepatocyte lipid content by increasing beta-oxidationEster Ciociola, Tanmoy Dutta, Kavitha Sasidharan, et al.
Pageof 10